Cargando…

NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma

Harnessing the immune adjuvant properties of natural killer T (NKT) cells is an effective strategy to generate anticancer immunity. The objective of this study was to increase the potency and durability of vaccine-induced immunity against B cell lymphoma by combining α-galactosylceramide (α-GalCer)-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Takumi, Doff, Brianna L, Rearden, Rory C, Leggatt, Graham R, Mattarollo, Stephen R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404843/ https://www.ncbi.nlm.nih.gov/pubmed/25949907 http://dx.doi.org/10.4161/2162402X.2014.990793

Ejemplares similares

γδ T cells augment rejection of skin grafts by enhancing cross priming of CD8 T cells to skin derived antigen
por: Rahimpour, Azad, et al.
Publicado: (2012)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

NKT Cell Responses to B Cell Lymphoma
por: Li, Junxin, et al.
Publicado: (2014)

CD8(+) T-cell immunity orchestrated by iNKT cells
por: Qin, Yingyu, et al.
Publicado: (2023)

PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy
por: Wright, Quentin, et al.
Publicado: (2021)

iNKT Cells Suppress the CD8(+) T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
por: Bjordahl, Ryan L., et al.
Publicado: (2012)

EBV Promotes Human CD8(+) NKT Cell Development
por: Yuling, He, et al.
Publicado: (2010)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Retraction: EBV Promotes Human CD8(+) NKT Cell Development
por: Yuling, He, et al.
Publicado: (2010)

Langerhans Cell Homeostasis and Activation Is Altered in Hyperplastic Human Papillomavirus Type 16 E7 Expressing Epidermis
por: Abd Warif, Nor Malia, et al.
Publicado: (2015)

Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction
por: Kuo, Paula, et al.
Publicado: (2018)

PD-1 abrogates the prolonged persistence of CD8(+) CAR-T cells with 4-1BB co-stimulation
por: Li, Feng, et al.
Publicado: (2020)

Antitumor Immunity Produced by the Liver Kupffer Cells, NK Cells, NKT Cells, and CD8(+) CD122(+) T Cells
por: Seki, Shuhji, et al.
Publicado: (2011)

Activated iNKT Cells Promote Memory CD8(+) T Cell Differentiation during Viral Infection
por: Reilly, Emma C., et al.
Publicado: (2012)

Can we define CD3(+)CD56(+) cells as NKT cells with impunity?
por: Lenart, Marzena, et al.
Publicado: (2021)

Invariant NKT Cells Regulate the CD8 T Cell Response during Theiler's Virus Infection
por: Mars, Lennart T., et al.
Publicado: (2014)

The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation
por: McCarthy, Corinna, et al.
Publicado: (2007)

Preferential and persistent impact of acute HIV-1 infection on CD4(+) iNKT cells in colonic mucosa
por: Paquin-Proulx, Dominic, et al.
Publicado: (2021)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Constitutive CD8 expression drives innate CD8(+) T-cell differentiation via induction of iNKT2 cells
por: Kojo, Satoshi, et al.
Publicado: (2020)

Invariant NKT cells are more abundant in peanut-allergic adults and a subset of CD8(+) iNKT cells are depleted after peanut oil exposure
por: Hopkins, Georgina V., et al.
Publicado: (2023)

Tregs constrain CD8(+) T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy
por: Palmeri, Joseph R., et al.
Publicado: (2023)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

Altered Development of NKT Cells, γδ T Cells, CD8 T Cells and NK Cells in a PLZF Deficient Patient
por: Eidson, Maggie, et al.
Publicado: (2011)

The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
por: Kuo, Paula T., et al.
Publicado: (2018)

Type II NKT cells differentially regulate CD4 T cell subsets
por: Robertson, Faith C, et al.
Publicado: (2014)

Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+ T Cells to Dendritic Cell-Based Vaccines
por: Petersen, Troels R., et al.
Publicado: (2011)

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
por: Rotolo, Antonia, et al.
Publicado: (2018)

Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells
por: Melgar-Rodríguez, Samanta, et al.
Publicado: (2021)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
por: Khan, Masood Alam, et al.
Publicado: (2021)

CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma
por: Rowan, Aileen G., et al.
Publicado: (2023)

CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis
por: Tupin, Emmanuel, et al.
Publicado: (2004)

The Function of CD3(+)CD56(+) NKT-Like Cells in HIV-Infected Individuals
por: Jiang, Yongjun, et al.
Publicado: (2014)

iNKT Cells Suppress Pathogenic NK1.1(+)CD8(+) T Cells in DSS-Induced Colitis
por: Lee, Sung Won, et al.
Publicado: (2018)

CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs
por: Wang, Chao, et al.
Publicado: (2015)

Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses
por: Leggatt, Graham R.
Publicado: (2014)

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma
por: Ying, Zhitao, et al.
Publicado: (2019)

Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells
por: Humphreys, Ian R, et al.
Publicado: (2010)

Trouble-making NKT cells
por: Van Epps, Heather L.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_cnpn8bhramov8c5kk8uhn05jfk